Canada markets closed

Anika Therapeutics, Inc. (ANIK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.590.00 (0.00%)
At close: 04:00PM EDT
27.59 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 409.12M
Enterprise Value 365.29M
Trailing P/E 43.00
Forward P/E 24.63
PEG Ratio (5 yr expected) 2.46
Price/Sales (ttm)2.43
Price/Book (mrq)1.93
Enterprise Value/Revenue 2.19
Enterprise Value/EBITDA -32.52

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52-Week Change 36.20%
S&P500 52-Week Change 322.38%
52 Week High 328.19
52 Week Low 316.54
50-Day Moving Average 325.60
200-Day Moving Average 322.14

Share Statistics

Avg Vol (3 month) 379.14k
Avg Vol (10 day) 347.42k
Shares Outstanding 514.83M
Implied Shares Outstanding 614.83M
Float 810.7M
% Held by Insiders 12.97%
% Held by Institutions 193.05%
Shares Short (Apr 15, 2024) 4811.11k
Short Ratio (Apr 15, 2024) 410.26
Short % of Float (Apr 15, 2024) 47.73%
Short % of Shares Outstanding (Apr 15, 2024) 45.46%
Shares Short (prior month Mar 15, 2024) 4766.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -49.60%
Operating Margin (ttm)56.80%

Management Effectiveness

Return on Assets (ttm)-2.36%
Return on Equity (ttm)-33.21%

Income Statement

Revenue (ttm)166.66M
Revenue Per Share (ttm)11.37
Quarterly Revenue Growth (yoy)8.50%
Gross Profit (ttm)N/A
EBITDA 2.52M
Net Income Avi to Common (ttm)-82.67M
Diluted EPS (ttm)-5.64
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)72.87M
Total Cash Per Share (mrq)4.97
Total Debt (mrq)29.04M
Total Debt/Equity (mrq)13.68%
Current Ratio (mrq)5.26
Book Value Per Share (mrq)14.48

Cash Flow Statement

Operating Cash Flow (ttm)-1.79M
Levered Free Cash Flow (ttm)12.58M